NEW YORK, March 13 – Xanthon of Research Triangle Park, NC, said Tuesday it would release its electrochemical DNA, RNA, and protein detection and analysis system for beta testing later this year, adding that the technology would offer potential users an alternative to reverse transcriptase PCR.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.